The Federal Trade Commission’s approach to reviewing hospital mergers “is overbroad, does not properly credit the many pro-consumer benefits of hospital transactions, and ignores key realities of the marketplace,” according to an analysis submitted to the agency Friday for a series of FTC hearings on Competition and Consumer Protection in the 21st Century. Performed for the AHA by Charles River Associates in conjunction with antitrust counsel at Wilson Sonsini Goodrich & Rosati, the analysis describes “serious flaws” in the supply and demand models that the FTC uses to evaluate the competitive effects of hospital transactions. “The Commission’s approach has substantial negative ramifications for U.S. consumers,” AHA said. “These include impeding the ability of hospitals and health care systems to develop more efficient platforms to care for tens of millions of Americans. The FTC’s approach also is placing hospitals at a serious disadvantage relative to the many new entrants to health care.”

Related News Articles

Headline
AHA’s Trustee Services July 8 released a new resource, “Building a Resilient Health Care Workforce,” which discusses how board leadership can shape strategies…
Headline
The AHA July 2 expressed support for the Resident Physician Shortage Reduction Act (H.R. 3890), bipartisan legislation that would add 14,000 Medicare-funded…
Headline
The Centers for Medicare & Medicaid Services June 27 announced the rollout of a 6-year technology-enabled prior authorization program pilot. Through…
Headline
Boston Medical Center’s Jeff Schneider, M.D., associate chief medical officer, designated institutional official and chair of the Graduate Medical Education…
Headline
The U.S. District Court for the Northern District of Iowa June 18 vacated components of the Centers for Medicare & Medicaid Services’ minimum nurse…
Blog
Public
Recent data from Press Ganey, reflecting input from over 1.4 million health care employees, reveals that after an initial post-pandemic rebound, employee…